Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / expert-strategy-memo.docx
expert-strategy-memo.docx
High · 2
Medium · 5
Standard · 2
I. Purpose and Executive Summary
Medium
⚑ Confidentiality undertaking
I. Purpose and Executive Summary This memorandum sets forth the comprehensive expert strategy for the preliminary injunction evidentiary hearing currently scheduled to begin September 8, 2025, with an estimated duration of five court days, before the Honorable Richard A. Johannsen, United States District Court for the Western District of Washington, Seattle Division. The hearing will address the Federal Trade Commiss
II. Overview of Expert Engagement
Medium
⚑ Confidentiality undertaking
II. Overview of Expert Engagement A. Brindoval Analytics LLC — Scope and Team Dr. Priya Ramanathan and her team at Brindoval Analytics LLC ("Brindoval") were retained via a written engagement agreement dated July 2, 2025, between Calderwood & Harkness LLP (acting on behalf of Cascade Retail Holdings Inc.) and Brindoval Analytics LLC. The engagement agreement provides for a flat fee of $1,800,000 for all expert servic
III. Dr. Ramanathan's Affirmative Expert Report — Structure and Key Opinions
Medium
⚑ Confidentiality undertaking
III. Dr. Ramanathan's Affirmative Expert Report — Structure and Key Opinions The following section outlines the five principal opinions that Dr. Ramanathan's affirmative expert report will present, along with the analytical framework, data inputs, and supporting evidence for each. This section is intended to serve as the substantive blueprint for the expert report and should be shared with Dr. Ramanathan and Dr. Engs
IV. Coordination Between Expert and Fact Witness Testimony
IV. Coordination Between Expert and Fact Witness Testimony The persuasive impact of Dr. Ramanathan's expert testimony at the evidentiary hearing depends critically on the factual foundation established by the defense's fact witnesses. Fact witnesses provide the real-world context, operational detail, and corporate perspective that give economic expert testimony its grounding and credibility. This section addresses th
1. Meg Thornberry (approximately half day) — Thornberry should testify first to establish
1. Meg Thornberry (approximately half day) — Thornberry should testify first to establish the corporate strategy and procompetitive rationale for the acquisition. Her testimony sets the narrative frame for the entire defense case: this is a merger driven by procompetitive motivations, occurring in a broad and dynamic e-commerce market.
2. Trish Delacroix (approximately half day) — Delacroix should testify second to provide
2. Trish Delacroix (approximately half day) — Delacroix should testify second to provide the detailed operational foundation for the efficiency claims. Her testimony establishes the specific facts — warehouse locations, per-unit cost data, technology infrastructure details, integration planning — that Dr. Ramanathan's efficiency analysis is built upon.
3. Rajiv Chandravar (approximately half day; called by Whitfield, Greer & Tanaka on behal
3. Rajiv Chandravar (approximately half day; called by Whitfield, Greer & Tanaka on behalf of Pinnacle) — Chandrasekaran should testify third to present Pinnacle's perspective on its competitive challenges. His testimony establishes the factual predicate for Dr. Ramanathan's weakening-competitor opinion.
4. Thomas Breck (brief direct examination; called by Whitfield, Greer & Tanaka) — Breck s
4. Thomas Breck (brief direct examination; called by Whitfield, Greer & Tanaka) — Breck should testify fourth to present the financial data supporting the weakening-competitor narrative. His testimony is focused and discrete, providing specific financial metrics that corroborate Chandrasekaran's broader strategic testimony.
5. Dr. Priya Ramanathan (full day) — Dr. Ramanathan should testify last among the defense
Medium
⚑ Confidentiality undertaking
5. Dr. Priya Ramanathan (full day) — Dr. Ramanathan should testify last among the defense witnesses. By testifying after all fact witnesses, she can reference their testimony and supporting documents, synthesize the factual record into a coherent economic narrative, and present her expert opinions as the capstone of the defense's evidentiary presentation. We note that Whitfield, Greer & Tanaka LLP — specifically Dian
V. Demonstrative Exhibits Strategy
Medium
⚑ Confidentiality undertaking
V. Demonstrative Exhibits Strategy Demonstrative exhibits will play a critical role at the evidentiary hearing. Judge Johannsen will be asked to absorb five days of dense economic testimony, including competing expert analyses of market definition, market shares, HHI calculations, diversion ratios, efficiency claims, and competitive effects. Clear, visually compelling demonstrative exhibits will be essential to makin
VI. Anticipated Cross-Examination of Dr. Wallace Keenan (FTC Expert)
VI. Anticipated Cross-Examination of Dr. Wallace Keenan (FTC Expert) This section addresses the anticipated cross-examination of Dr. Wallace Keenan, the FTC's testifying expert. Our cross-examination strategy is designed to undermine the credibility and reliability of Dr. Keenan's opinions on market definition, concentration, and competitive effects, while preserving themes that support Dr. Ramanathan's affirmative t
1. Market Definition. Dr. Keenan will support the FTC's proposed relevant product market
1. Market Definition. Dr. Keenan will support the FTC's proposed relevant product market of "online marketplace platform services for third-party sellers in the United States." He will likely present this market as a distinct product market separate from DTC e-commerce, social commerce, and other forms of online retail, based on the assertion that marketplace platforms offer a functionally distinct service — connecti
2. SSNIP Test. Dr. Keenan will present a SSNIP test analysis purporting to demonstrate th
Standard
⚑ Commercial term
2. SSNIP Test. Dr. Keenan will present a SSNIP test analysis purporting to demonstrate that a hypothetical monopolist of marketplace platform services could profitably impose a small but significant non-transitory increase in seller take rates — from the current industry range of approximately 16–17% to a level approximately 5–10% higher — without losing a sufficient volume of sellers to render the increase unprofita
3. HHI Calculations. Dr. Keenan will present HHI calculations showing pre-merger concentr
3. HHI Calculations. Dr. Keenan will present HHI calculations showing pre-merger concentration of 2,361 and post-merger concentration of 2,856, with a delta of 495. He will note that both the post-merger HHI and the delta substantially exceed the 2023 Merger Guidelines' thresholds for a presumption of illegality in "highly concentrated" markets (post-merger HHI exceeding 2,500 with a delta exceeding 200).
4. Unilateral Effects. Dr. Keenan will present a unilateral effects analysis based on sel
4. Unilateral Effects. Dr. Keenan will present a unilateral effects analysis based on seller-side diversion ratios between CascadeMarket and Pinnacle. This analysis will purport to demonstrate significant competitive overlap between the two platforms — i.e., that a substantial share of sellers who would leave one platform in response to a take-rate increase would divert to the other platform. Using these diversion ra
5. Efficiency Critique. Dr. Keenan may opine that Cascade's claimed $340 million in annua
5. Efficiency Critique. Dr. Keenan may opine that Cascade's claimed $340 million in annual merger-specific efficiencies are not verifiable, not merger-specific, or unlikely to be achieved in the magnitude claimed. Specifically, he may argue that Pinnacle could independently contract with third-party logistics providers to improve its fulfillment capabilities without the need for a full merger with Cascade. B. Lines o
1. Failure to Account for Supply-Side Substitution in SSNIP Test. Dr. Keenan's SSNIP test
High
⚑ Non-compete / exclusivity restraint
1. Failure to Account for Supply-Side Substitution in SSNIP Test. Dr. Keenan's SSNIP test likely focuses exclusively on demand-side substitution — whether sellers would leave marketplace platforms in response to a take-rate increase. However, a properly conducted SSNIP test must also consider supply-side substitution — whether firms currently outside the hypothetical monopolist's market could rapidly and profitably b
2. Two-Sided Market Analysis. We will probe whether Dr. Keenan properly accounted for the
Standard
⚑ Commercial term
2. Two-Sided Market Analysis. We will probe whether Dr. Keenan properly accounted for the two-sided nature of marketplace platforms. Under the framework articulated by the Supreme Court's decision in Ohio v. Halcyon Corporation, 585 U.S. 529 (2018), the competitive analysis of a two-sided platform must consider the effects on both sides of the platform. Did Dr. Keenan analyze both seller-side and buyer-side (consumer
3. Treatment of Multi-Homing. We will question the reliability of Dr. Keenan's seller-side
High
⚑ Non-compete / exclusivity restraint
3. Treatment of Multi-Homing. We will question the reliability of Dr. Keenan's seller-side diversion ratios by probing his treatment of multi-homing behavior. If a substantial percentage of Pinnacle sellers also sell on Vertex Commerce, Nomad Shops, or DTC channels, the diversion ratio between CascadeMarket and Pinnacle is overstated because sellers who multi-home across multiple platforms have additional options for
4. Inconsistency in Market Share Calculations. We will highlight an internal tension in th
4. Inconsistency in Market Share Calculations. We will highlight an internal tension in the FTC's market share calculations. The FTC's own market shares — Cascade at 8.2%, Pinnacle at 30.1%, Vertex Commerce at 35.7%, Nomad Shops at 14.6%, and all others at 11.4% — treat the "all others" category at 11.4%, which includes Brevity Social Commerce, Trove Marketplace, and numerous smaller platforms. If these "others" repr
5. Static vs. Dynamic Analysis. We will probe whether Dr. Keenan's analysis adequately acc
5. Static vs. Dynamic Analysis. We will probe whether Dr. Keenan's analysis adequately accounts for the rapid pace of entry, innovation, and competitive repositioning in the e-commerce sector. Marketplace platforms that did not exist three years ago — Brevity Social Commerce and Trove Marketplace — now compose part of the competitive landscape. The pace of technological change and business model innovation in e-comme
6. Treatment of Pinnacle's Weakening Position. We will probe whether Dr. Keenan's competit
6. Treatment of Pinnacle's Weakening Position. We will probe whether Dr. Keenan's competitive effects model incorporates Pinnacle's decelerating growth trajectory (28% YoY in 2022 declining to 9% YoY in 2024) and increasing seller churn (12% in 2022 increasing to 21% in 2024). If Dr. Keenan's model treats Pinnacle's current 30.1% market share as static — without accounting for the likelihood that Pinnacle's share wil
7. Prior Engagements and Potential Bias. We will explore Dr. Keenan's history of engagemen
7. Prior Engagements and Potential Bias. We will explore Dr. Keenan's history of engagements on behalf of the FTC and other government antitrust agencies. If Dr. Keenan has a pattern of consistently testifying in support of narrow market definitions and against proposed mergers on behalf of government agencies, this pattern is relevant to the weight the Court should give his opinions. We will also assess whether Dr.